McCarthy, Cathal
Kenny, Louise C.
Article History
Received: 28 January 2016
Accepted: 15 August 2016
First Online: 8 September 2016
Competing interests
: L.C. Kenny is a minority shareholder in Metabolomic Diagnostics, a campus-based spin-out that has licensed technology concerning the use of metabolomics biomarkers in the prediction of preeclampsia.